Antibiotic Policy Solutions An Ocean Apart Between U.S., EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Governments are taking on different initiatives to solve the problem of developing products to address worries about drug-resistant bacteria. The EU is helping to fund trials, while the U.S. is offer extended exclusivity.